advertisement
Abstract #106328 Published in IGR 23-3
In Vitro Evaluation of Zinc Oxide Tetrapods as a New Material Component for Glaucoma Implants
Sonntag SR; Sonntag SR; Gniesmer S; Gniesmer S; Gapeeva A; Gapeeva A; Offermann KJ; Adelung R; Adelung R; Mishra YK; Mishra YK; Cojocaru A; Cojocaru A; Kaps S; Kaps S; Grisanti S; Tura ALife (Basel, Switzerland) 2022; 12:
In our previous study we were able to show that zinc oxide (ZnO) tetrapods inhibit wound healing processes. Therefore, the aim of this study was to test the antiproliferative effect of two types of porous polydimethylsiloxane (PDMS)/ tetrapodal zinc oxide (ZnO-T) materials, as well as their usability for glaucoma implants. To find the best implant material, two different porous PDMS/ZnO-T materials were examined. One consisted of 3D interconnected PDMS coarse-pored foams with protruding ZnO-T particles; the other consisted of fine-pored 3D interconnected ZnO-T networks homogeneously coated by a thin PDMS film in the nanometer range. Fibroblast cell viability was investigated for both materials via MTT dye, and some implant material samples were further processed for electron microscopy. Both PDMS/ZnO-T materials showed reduced cell viability in the MTT staining. Furthermore, the electron microscopy revealed barely any fibroblasts growing on the implant materials. At the surface of the fine-pored implant material, however, fibroblasts could not be observed in the etched control samples without ZnO-T. It was found that post-processing of the material to the final stent diameter was highly challenging and that the fabrication method, therefore, had to be adapted. In conclusion, we were able to demonstrate the antiproliferative potential of the two different PDMS/ZnO-T materials. Furthermore, smaller pore size (in the range of tens of micrometers) in the implant material seems to be preferable.
Department of Ophthalmology, University of Luebeck, 23538 Luebeck, Germany.
Full article